{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,16]],"date-time":"2023-09-16T16:18:23Z","timestamp":1694881103263},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2005,8,1]],"date-time":"2005-08-01T00:00:00Z","timestamp":1122854400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2005,8]]},"DOI":"10.1007\/s10620-005-2870-8","type":"journal-article","created":{"date-parts":[[2005,7,21]],"date-time":"2005-07-21T06:17:13Z","timestamp":1121926633000},"page":"1513-1516","source":"Crossref","is-referenced-by-count":6,"title":["13C-Urea Breath Test for Success of Helicobacter pylori Eradication: Study of 5885 Israeli Patients."],"prefix":"10.1007","volume":"50","author":[{"given":"Y.","family":"Niv","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Koren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"2870_CR1","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S0889-8553(05)70130-8","volume":"29","author":"JE Everhart","year":"2000","unstructured":"Everhart JE: Recent developments in the epidemiology of Helicobacter pylori. Gastroenterol Clin North Am 29:559\u2013578, 2000","journal-title":"Gastroenterol Clin North Am"},{"issue":"Suppl","key":"2870_CR2","doi-asserted-by":"crossref","first-page":"s11","DOI":"10.1016\/S0002-9270(99)00657-7","volume":"94","author":"MP Williams","year":"1999","unstructured":"Williams MP, Pounder RE: Helicobacter pylori: from the benign to the malignant. Am J Gastroenterol 94 (Suppl):s11\u2013s16, 1999","journal-title":"Am J Gastroenterol"},{"issue":"Suppl 1","key":"2870_CR3","first-page":"118","volume":"45","author":"V Savarino","year":"1999","unstructured":"Savarino V, Vigneri S, Celle G: The 13C urea breath test in the diagnosis of Helicobacter pylori infection. Gut 45 (Suppl 1):118\u2013122, 1999","journal-title":"Gut"},{"key":"2870_CR4","first-page":"135","volume":"71","author":"BH Novis","year":"1998","unstructured":"Novis BH, Gabay G, Naftali T: Helicobacter pylori: the Middle East scenario. Yale J Biol Med 71:135\u2013141, 1998","journal-title":"Yale J Biol Med"},{"key":"2870_CR5","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1093\/jac\/dkf041","volume":"46","author":"Z Samra","year":"2002","unstructured":"Samra Z, Shmueli H, Niv Y, Dinari G, Ofek I, Passaro DJ, Geler A, Gal E. Fishman M, Bachor J, Yahav J: Resistance of Helicobactor pylori isolates in Israel to metronidazole, Clarithromytcin, tetracycline, amoxicillin and cefoxime. J Antimicrob Chemother 46:1023\u20131026, 2002","journal-title":"J Antimicrob Chemother"},{"issue":"Suppl 1","key":"2870_CR6","doi-asserted-by":"crossref","first-page":"s47","DOI":"10.1136\/gut.43.2008.S47","volume":"43","author":"RP Logan","year":"1998","unstructured":"Logan RP: Urea breath tests in the management of Helicobacter pylori infection. Gut 43 (Suppl 1):s47\u2013s50, 1998","journal-title":"Gut"},{"key":"2870_CR7","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/00365519850186797","volume":"58","author":"F Perri","year":"1998","unstructured":"Perri F, Clemente R, Pastore M, Quitadamo M, Festa V, Bisceglia M, Li Bergoli M, Lauriola G, Leandro G, Ghoos Y, Rutgeerts P, Andriulli A: The 13C urea breath test as a predictor of intragastric bacterial load and severity of Helicobacter pylori gastritis. Scand J Clin Lab Invest 58:19\u201327, 1998","journal-title":"Scand J Clin Lab Invest"},{"key":"2870_CR8","first-page":"2057","volume":"46","author":"BS Sheu","year":"1999","unstructured":"Sheu BS, Lee SC, Yang HB, Lin XZ: Quantitative results of 13C urea breath test at 15 minutes may correlate with the bacterial density of H. pylori in the stomach. Hepatogastroenterology 46:2057\u20132062, 1999","journal-title":"Hepatogastroenterology"},{"key":"2870_CR9","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/BF02789178","volume":"11","author":"PR Hawtin","year":"1999","unstructured":"Hawtin PR: Serology and urea breath test in the diagnosis of H. pylori infection. Mol Biotechnol 11:85\u201392, 1999","journal-title":"Mol Biotechnol"},{"key":"2870_CR10","first-page":"85","volume":"91","author":"AF Cutler","year":"1996","unstructured":"Cutler AF, Prasad VM: Long term follow-up of Helicobacter pylori serology after successful eradication. Am J Gastroenterol91:85\u201388, 1996","journal-title":"Am J Gastroenterol"},{"key":"2870_CR11","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1086\/516089","volume":"25","author":"GI Perez-Perz","year":"1997","unstructured":"Perez-Perz GI, Culter AF, Blaser MJ: Value of serology as a noninvasive method for evaluating the efficacy of treatment of Helicobacter pylori infection. Clin Infect Dis 25:1038\u20131043, 1997","journal-title":"Clin Infect Dis"},{"key":"2870_CR12","doi-asserted-by":"crossref","unstructured":"Peterson WL, Graham DY: Helicobacter pylori. In Sleisenger & Fordtran\u2019s Gastrointestinal and Liver Disease, 6th ed. W. B. Saunders, Philadelphia, 1998, pp 604\u2013619","DOI":"10.1016\/S0016-5085(98)70657-2"},{"key":"2870_CR13","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1046\/j.1365-2036.2002.01169.x","volume":"16","author":"P Malfertheiner","year":"2001","unstructured":"Malfertheiner P, Megraud F, O\u2019Morain C, Hungin APS, Jones R, Axon A, Graham DY, Tytgat G: The European Helicobacter Study Group, Maastricht II, 2000. Aliment Pharmacol Ther16:167\u2013180, 2001","journal-title":"Aliment Pharmacol Ther"},{"key":"2870_CR14","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1056\/NEJM199812243392601","volume":"339","author":"K McColl","year":"1998","unstructured":"McColl K, Murray L, El-Omar E, Dickson A, El-Nujumi A, Wirz A, Kelman A, Penny C, Knill-Jones R, Hilditch T: Symptomatic benefit from eradicating Helicobacter pyloriinfection in patients with nonulcer dyspepsia. N Engl J Med 339:1869\u20131874, 1998","journal-title":"N Engl J Med"},{"key":"2870_CR15","first-page":"790","volume":"92","author":"B Annibale","year":"1997","unstructured":"Annibale B, D\u2019Ambra G, Luzzi I, Marcheggiano A, Lannoni C, Paoletti M, Anania MC, Marignani M, Dell Fave G: Does pretreatment with omeprazole decrease the chance of eradication of Helicobacter pylori in peptic ulcer patients? Am J Gastroenterol 92:790\u2013794, 1997","journal-title":"Am J Gastroenterol"},{"key":"2870_CR16","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/BF01213292","volume":"32","author":"P Moayyedi","year":"1997","unstructured":"Moayyedi P, Chalmers DM, Axon AT: Patient factors that predict failure of omeprazole, clarithromycin, and tinidazole to eradicate Helicobacter pylori. J Gastroenterol 32:24\u201327, 1997","journal-title":"J Gastroenterol"},{"key":"2870_CR17","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1046\/j.1365-2036.2001.01006.x","volume":"15","author":"F Perri","year":"2001","unstructured":"Perri F, Villani MR, Festa V, Quitadamo M, Andriulli A: Predictors of failure of Helicobacter pylori eradication with the standard \u201cMaastricht triple therapy.\u201d Aliment Pharmacol Ther 15:1023\u20131029, 2001","journal-title":"Aliment Pharmacol Ther"},{"key":"2870_CR18","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1046\/j.1523-5378.1998.08032.x","volume":"3","author":"Z Fireman","year":"1998","unstructured":"Fireman Z, Segal A, Moshkowitz M, Kopelman Y, Sterenberg A: Helicobacter pylori and peptic disease therapies: a survey of gastroenterologists in Israel. Helicobacter 3:93\u201396, 1998","journal-title":"Helicobacter"},{"key":"2870_CR19","first-page":"272","volume":"137","author":"B Avidan","year":"1999","unstructured":"Avidan B, Weiss B, Chowers Y, Younash A, Bar-Meir S, Keler N: Sensitivity and resistance of Helicobacter pylori to antibiotic treatment. Harefuah 137:272\u2013274, 1999","journal-title":"Harefuah"},{"key":"2870_CR20","first-page":"A295","volume":"110","author":"AS Weisfeld","year":"1996","unstructured":"Weisfeld AS, Simmons DE, Vance PH: In vitro susceptibility of pre-treatment isolates of Helicobacter pylori from the multicenter United States clinical trials. Gastroenterology 110:A295, 1996 (abstr)","journal-title":"Gastroenterology"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-005-2870-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10620-005-2870-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-005-2870-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T19:35:37Z","timestamp":1559244937000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10620-005-2870-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,8]]},"references-count":20,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2005,8]]}},"alternative-id":["2870"],"URL":"https:\/\/doi.org\/10.1007\/s10620-005-2870-8","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,8]]}}}